Apoptotic response to camptothecin and 7-hydroxystaurosporine (UCN-01) in the 8 human breast cancer cell lines of the NCI anticancer drug screen: Multifactorial relationships with topoisomerase i, protein kinase C, Bcl-2, p53, MDM-2 and caspase pathways
- 30 July 1999
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 82 (3), 396-404
- https://doi.org/10.1002/(sici)1097-0215(19990730)82:3<396::aid-ijc13>3.0.co;2-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Cell Death in DevelopmentCell, 1999
- Bcl-xL Modulates Apoptosis Induced by Anticancer Drugs and Delays DEVDase and DNA Fragmentation-Promoting ActivitiesExperimental Cell Research, 1998
- Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with ApoptosisJournal of Biological Chemistry, 1998
- Expression of multiple apoptosis-regulatory genes in human breast cancer cell lines and primary tumorsBreast Cancer Research and Treatment, 1998
- Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cellsOncogene, 1997
- UCN-01: a Potent Abrogator of G2 Checkpoint Function in Cancer Cells With Disrupted p53JNCI Journal of the National Cancer Institute, 1996
- Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosisInternational Journal of Cancer, 1996
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Characterization of camptothecin-resistant chinese hamster lung cellsBiochemical Pharmacology, 1992
- Mutations in p53 as potential molecular markers for human breast cancer.Proceedings of the National Academy of Sciences, 1991